Developing Drugs to Decrease the Toxicity of Chemotherapy
- 15 July 2001
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (14), 3439-3441
- https://doi.org/10.1200/jco.2001.19.14.3439
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast CancerJournal of Clinical Oncology, 2001
- American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy ProtectantsJournal of Clinical Oncology, 1999
- Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.Journal of Clinical Oncology, 1997
- Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.Journal of Clinical Oncology, 1997